Department of Global Health Policy, Graduate School of Medicine, School of Public Health, The University of Tokyo, Tokyo, Japan.
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Lancet. 2017 Sep 23;390(10101):1521-1538. doi: 10.1016/S0140-6736(17)31544-1. Epub 2017 Jul 19.
Japan has entered the era of super-ageing and advanced health transition, which is increasingly putting pressure on the sustainability of its health system. The level and pace of this health transition might vary across regions within Japan and concern is growing about increasing regional variations in disease burden. The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) provides a comprehensive, comparable framework. We used data from GBD 2015 with the aim to quantify the burden of disease and injuries, and to attribute risk factors in Japan at a subnational, prefecture-level.
We used data from GBD 2015 for 315 causes and 79 risk factors of death, disease, and injury incidence and prevalence to measure the burden of diseases and injuries in Japan and in the 47 Japanese prefectures from 1990 to 2015. We extracted data from GBD 2015 to assess mortality, causes of death, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), life expectancy, and healthy life expectancy (HALE) in Japan and its 47 prefectures. We split extracted data by prefecture and applied GBD methods to generate estimates of burden, and attributable burden due to known risk factors. We examined the prefecture-level relationships of common health system inputs (eg, health expenditure and workforces) to the GBD outputs in 2015 to address underlying determinants of regional health variations.
Life expectancy at birth in Japan increased by 4·2 years from 79·0 years (95% uncertainty interval [UI] 79·0 to 79·0) to 83·2 years (83·1 to 83·2) between 1990 and 2015. However, the gaps between prefectures with the lowest and highest life expectancies and HALE have widened, from 2·5 to 3·1 years and from 2·3 to 2·7 years, respectively, from 1990 to 2015. Although overall age-standardised death rates decreased by 29·0% (28·7 to 29·3) from 1990 to 2015, the rates of mortality decline in this period substantially varied across the prefectures, ranging from -32·4% (-34·8 to -30·0) to -22·0% (-20·4 to -20·1). During the same time period, the rate of age-standardised DALYs was reduced overall by 19·8% (17·9 to 22·0). The reduction in rates of age-standardised YLDs was very small by 3·5% (2·6 to 4·3). The pace of reduction in mortality and DALYs in many leading causes has largely levelled off since 2005. Known risk factors accounted for 34·5% (32·4 to 36·9) of DALYs; the two leading behavioural risk factors were unhealthy diets and tobacco smoking in 2015. The common health system inputs were not associated with age-standardised death and DALY rates in 2015.
Japan has been successful overall in reducing mortality and disability from most major diseases. However, progress has slowed down and health variations between prefectures is growing. In view of the limited association between the prefecture-level health system inputs and health outcomes, the potential sources of regional variations, including subnational health system performance, urgently need assessment.
Bill & Melinda Gates Foundation, Japan Ministry of Education, Science, Sports and Culture, Japan Ministry of Health, Labour and Welfare, AXA CR Fixed Income Fund and AXA Research Fund.
日本已进入超级老龄化和先进健康转型的时代,这给其卫生系统的可持续性带来了越来越大的压力。日本各地区的健康转型水平和速度可能存在差异,人们越来越担心疾病负担的地区差异不断扩大。2015 年全球疾病、伤害和危险因素研究(GBD 2015)提供了一个全面、可比的框架。我们使用 GBD 2015 中的数据,旨在量化日本各地区的疾病和伤害负担,并归因于 79 个风险因素。
我们使用 GBD 2015 中的 315 个死因和 79 个疾病、伤害发病和流行的风险因素数据,以衡量日本及其 47 个都道府县 1990 年至 2015 年期间的疾病和伤害负担。我们从 GBD 2015 中提取数据,以评估日本及其 47 个都道府县的死亡率、死因、寿命损失年(YLL)、失能生命年(YLD)、伤残调整生命年(DALY)、预期寿命和健康期望寿命(HALE)。我们按都道府县划分提取数据,并应用 GBD 方法生成负担和归因于已知风险因素的负担。我们检查了 2015 年常见卫生系统投入(如卫生支出和劳动力)与 GBD 产出之间的都道府县关系,以解决区域卫生差异的潜在决定因素。
1990 年至 2015 年期间,日本出生时的预期寿命从 79.0 岁(95%不确定性区间[UI]79.0 至 79.0)增加到 83.2 岁(83.1 至 83.2),增加了 4.2 岁。然而,1990 年至 2015 年间,出生时预期寿命和 HALE 最低和最高的都道府县之间的差距已经扩大,分别从 2.5 岁扩大到 3.1 岁,从 2.3 岁扩大到 2.7 岁。尽管总体上年龄标准化死亡率从 1990 年的 28.7%下降到 2015 年的 29.3%,但在此期间,死亡率的下降在各都道府县之间存在很大差异,范围从-32.4%(-34.8 至-30.0)到-22.0%(-20.4 至-20.1)。同期,年龄标准化 DALY 率下降了 19.8%(17.9 至 22.0)。年龄标准化 YLD 率的下降幅度非常小,为 3.5%(2.6 至 4.3)。自 2005 年以来,许多主要死因的死亡率和 DALY 下降速度已基本趋缓。已知风险因素占 DALY 的 34.5%(32.4 至 36.9);2015 年两个主要的行为风险因素是不健康的饮食和吸烟。常见的卫生系统投入与 2015 年的年龄标准化死亡率和 DALY 率没有关联。
日本在降低大多数主要疾病的死亡率和残疾率方面总体上取得了成功。然而,进展已经放缓,各都道府县之间的健康差异也在扩大。鉴于都道府县卫生系统投入与卫生结果之间的关联有限,包括国家以下卫生系统绩效在内的潜在区域差异来源急需评估。
比尔及梅琳达·盖茨基金会、日本文部科学省、日本厚生劳动省、AXA CR 固定收益基金和 AXA 研究基金。